SK Life Science Labs
Debangshu Samanta, Ph.D., is a highly experienced Senior Scientist specializing in Cancer Biology at SK Life Science Labs since October 2021, where expertise in target identification has led to the proposal of ten new targets for clinical evaluation. Prior to this role, Debangshu worked as a Scientist in Lead Discovery at The Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on assay development and advanced imaging for drug discovery. At Johns Hopkins Medicine, experience as an Instructor involved the design and execution of innovative experiments to enhance immunotherapy, as well as managing research associates. Debangshu's academic background includes a Ph.D. in Oncology and Cancer Biology from Vanderbilt University, alongside master's degrees in Physics from Florida State University and Jawahar Lal Nehru University, and a bachelor's degree in Physics from Presidency College, India.
This person is not in any teams
SK Life Science Labs
SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, is a U.S. biotech company focused on the discovery of transformative medicines through targeted protein degradation (TPD). We discover and develop therapies through precise degradation of disease-causing proteins. Our team takes a target-centric approach through AI enabled target identification. Our core TPD platform, built upon a strong TPD knowledge base, novel E3 ligands & linkers, and machine-learning based ternary complex modeling, is further complemented by a proprietary MOPED™ molecular glue platform. SK Life Science Labs integrates innovative platforms with deep drug-hunting expertise to defeat disease and improve patients’ lives. View our community guidelines here: http://bit.ly/3REsFKU